Kesselheim AS - Search Results

1

Differences in rates of switchbacks after switching from branded to authorized generic and branded to generic drug products: cohort study.

Desai RJ, Sarpatwari A, Dejene S, Khan NF, Lii J, Rogers JR, Dutcher SK, Raofi S, Bohn J, Connolly J, Fischer MA, Kesselheim AS, Gagne JJ. Desai RJ, et al. Among authors: kesselheim as. BMJ. 2018 Apr 3;361:k1180. doi: 10.1136/bmj.k1180. BMJ. 2018. PMID: 29615391 Free PMC article.

2

The rise and fall of Natrecor for congestive heart failure: implications for drug policy.

Kesselheim AS, Fischer MA, Avorn J. Kesselheim AS, et al. Health Aff (Millwood). 2006 Jul-Aug;25(4):1095-102. doi: 10.1377/hlthaff.25.4.1095. Health Aff (Millwood). 2006. PMID: 16835191

3

Extensions of intellectual property rights and delayed adoption of generic drugs: effects on medicaid spending.

Kesselheim AS, Fischer MA, Avorn J. Kesselheim AS, et al. Health Aff (Millwood). 2006 Nov-Dec;25(6):1637-47. doi: 10.1377/hlthaff.25.6.1637. Health Aff (Millwood). 2006. PMID: 17102189

4

Clinical equivalence of generic and brand-name drugs used in cardiovascular disease: a systematic review and meta-analysis.

Kesselheim AS, Misono AS, Lee JL, Stedman MR, Brookhart MA, Choudhry NK, Shrank WH. Kesselheim AS, et al. JAMA. 2008 Dec 3;300(21):2514-26. doi: 10.1001/jama.2008.758. JAMA. 2008. PMID: 19050195 Free PMC article. Review.

5

Seizure outcomes following the use of generic versus brand-name antiepileptic drugs: a systematic review and meta-analysis.

Kesselheim AS, Stedman MR, Bubrick EJ, Gagne JJ, Misono AS, Lee JL, Brookhart MA, Avorn J, Shrank WH. Kesselheim AS, et al. Drugs. 2010 Mar 26;70(5):605-21. doi: 10.2165/10898530-000000000-00000. Drugs. 2010. PMID: 20329806 Free PMC article. Review.

6

State generic substitution laws can lower drug outlays under Medicaid.

Shrank WH, Choudhry NK, Agnew-Blais J, Federman AD, Liberman JN, Liu J, Kesselheim AS, Brookhart MA, Fischer MA. Shrank WH, et al. Among authors: kesselheim as. Health Aff (Millwood). 2010 Jul;29(7):1383-90. doi: 10.1377/hlthaff.2009.0424. Health Aff (Millwood). 2010. PMID: 20606192 Free PMC article.

7

The consequences of requesting "dispense as written".

Shrank WH, Liberman JN, Fischer MA, Avorn J, Kilabuk E, Chang A, Kesselheim AS, Brennan TA, Choudhry NK. Shrank WH, et al. Among authors: kesselheim as. Am J Med. 2011 Apr;124(4):309-17. doi: 10.1016/j.amjmed.2010.11.020. Am J Med. 2011. PMID: 21435421

8

Patterns and predictors of generic narrow therapeutic index drug use among older adults.

Gagne JJ, Polinski JM, Kesselheim AS, Choudhry NK, Hutchins D, Matlin OS, Tong A, Shrank WH. Gagne JJ, et al. Among authors: kesselheim as. J Am Geriatr Soc. 2013 Sep;61(9):1586-91. doi: 10.1111/jgs.12399. Epub 2013 Sep 3. J Am Geriatr Soc. 2013. PMID: 24001285

9

Strategies for postmarketing surveillance of drugs for rare diseases.

Kesselheim AS, Gagne JJ. Kesselheim AS, et al. Clin Pharmacol Ther. 2014 Mar;95(3):265-8. doi: 10.1038/clpt.2013.218. Epub 2013 Nov 5. Clin Pharmacol Ther. 2014. PMID: 24193169 Review.

10

Using a drug-safety tool to prevent competition.

Sarpatwari A, Avorn J, Kesselheim AS. Sarpatwari A, et al. Among authors: kesselheim as. N Engl J Med. 2014 Apr 17;370(16):1476-8. doi: 10.1056/NEJMp1400488. N Engl J Med. 2014. PMID: 24738666 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

720 results

Search Page